Dubai, UAE, March 31, 2025 (GLOBE NEWSWIRE) — Between traditional banks, digital wallets, crypto exchanges, and specialized financial tools, companies often find themselves bouncing between multiple accounts, apps, and cards just to handle everyday transactions. This fragmented banking system isn't just inconvenient – it is costly, inefficient, and poses a higher security risk. As each […]
(NYSE MKT:CATX), SEATTLE, March 31, 2025 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced that members of its senior leadership team will participate in and be available for one-on-one meetings with investors at the
(NASDAQ:RVYL), – Reiterates 2025 guidance of $80 million to $90 million in revenue and mid-40s percentage gross margin – SAN DIEGO, CA, March 31, 2025 (GLOBE NEWSWIRE) — RYVYL Inc. (NASDAQ: RVYL) (“RYVYL” or the “Company”), a leading innovator of payment transaction solutions leveraging electronic payment technology for the diverse international markets, reported its financial
(NASDAQ:CABA), – FDA meeting to align on myositis registrational trial designs for rese-cel in 1H25 on track – – Enrolling approximately one patient per week across the RESET(TM) clinical development program since ACR Convergence presentation in November 2024 with 33 patients enrolled across 56 active clinical trial sites in the U.S. & Europe as of
(NasdaqGM:OCUL), BEDFORD, Mass., March 31, 2025 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced that the Company will participate in two investor conferences in April: 24th Annual Needham Virtual Healthcare ConferencePresentation Date: Monday, April 7, 2025Presentation Time: 3:00 PM ETPresenter: Pravin U. Dugel,
(NasdaqGM:USAR),(NasdaqGM:USARW), Magnet recipe development and customer qualification work set to begin in support of full magnet production in 2026 “We're Open for Business,” says CEO Joshua Ballard STILLWATER, Okla., March 31, 2025 (GLOBE NEWSWIRE) — USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company), today announced it has commissioned its advanced Innovations Lab at
(NASDAQ:WKHS), CINCINNATI, March 31, 2025 (GLOBE NEWSWIRE) — Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today reported financial results for the full year ended December 31, 2024. Management Commentary “During the past year, we continued to strengthen and expand our
(NASDAQ:VERO), TORONTO, March 31, 2025 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve months ended December 31, 2024. Summary of Financial Results & Recent Progress: Company continues to execute against Transformation Plan Cash used in operations
(TSX-V:MATA),(OTC US:MTDTF),(OtherOTC:MTDTF), TORONTO, March 31, 2025 (GLOBE NEWSWIRE) — Matador Technologies Inc. (“Matador” or the “Company”) (TSXV: MATA, OTCQB: MTDTF) announces the addition of two members to its team as the Company advances toward the launch of its digital gold product on the Bitcoin network in early 2025. Antoine De Vuyst has joined Matador as
Dr. William Sellers is a leading cancer researcher who currently serves as a Core Institute member and Director of the cancer program at the Broad Institute and a professor of medicine at Dana-Farber Cancer Institute and Harvard Medical School He brings deep expertise and experience in cancer biology and cancer therapeutics to Atavistik Bio as